Unknown

Dataset Information

National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys.


ABSTRACT:

Background

Recent pilot trials have demonstrated the safety of transplanting HCV-viremic kidneys into HCV-seronegative recipients. However, it remains unclear if allograft function is impacted by donor HCV-viremia or recipient HCV-serostatus.

Methods

We used national United States registry data to examine trends in HCV-viremic kidney use between 4/1/2015 and 3/31/2019. We applied advanced matching methods to compare eGFR for similar kidneys transplanted into highly similar recipients of kidney transplants.

Results

Over time, HCV-seronegative recipients received a rising proportion of HCV-viremic kidneys. During the first quarter of 2019, 200 HCV-viremic kidneys were transplanted into HCV-seronegative recipients, versus 69 into HCV-seropositive recipients, while 105 HC

SUBMITTER: Potluri VS 

PROVIDER: S-EPMC6779360 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature